BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8754809)

  • 1. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia.
    Golub TR; Goga A; Barker GF; Afar DE; McLaughlin J; Bohlander SK; Rowley JD; Witte ON; Gilliland DG
    Mol Cell Biol; 1996 Aug; 16(8):4107-16. PubMed ID: 8754809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways.
    Carroll M; Tomasson MH; Barker GF; Golub TR; Gilliland DG
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14845-50. PubMed ID: 8962143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.
    Lacronique V; Boureux A; Monni R; Dumon S; Mauchauffé M; Mayeux P; Gouilleux F; Berger R; Gisselbrecht S; Ghysdael J; Bernard OA
    Blood; 2000 Mar; 95(6):2076-83. PubMed ID: 10706877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
    Golub TR; Barker GF; Bohlander SK; Hiebert SW; Ward DC; Bray-Ward P; Morgan E; Raimondi SC; Rowley JD; Gilliland DG
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4917-21. PubMed ID: 7761424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ARG tyrosine kinase activity is inhibited by STI571.
    Okuda K; Weisberg E; Gilliland DG; Griffin JD
    Blood; 2001 Apr; 97(8):2440-8. PubMed ID: 11290609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEL/PDGFbetaR fusion protein activates STAT1 and STAT5: a common mechanism for transformation by tyrosine kinase fusion proteins.
    Wilbanks AM; Mahajan S; Frank DA; Druker BJ; Gilliland DG; Carroll M
    Exp Hematol; 2000 May; 28(5):584-93. PubMed ID: 10812249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines.
    Okuda K; Golub TR; Gilliland DG; Griffin JD
    Oncogene; 1996 Sep; 13(6):1147-52. PubMed ID: 8808688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemopoietic transformation by the TEL/ABL oncogene.
    Hannemann JR; McManus DM; Kabarowski JH; Wiedemann LM
    Br J Haematol; 1998 Jul; 102(2):475-85. PubMed ID: 9695962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein.
    Jousset C; Carron C; Boureux A; Quang CT; Oury C; Dusanter-Fourt I; Charon M; Levin J; Bernard O; Ghysdael J
    EMBO J; 1997 Jan; 16(1):69-82. PubMed ID: 9009269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia.
    Lacronique V; Boureux A; Valle VD; Poirel H; Quang CT; Mauchauffé M; Berthou C; Lessard M; Berger R; Ghysdael J; Bernard OA
    Science; 1997 Nov; 278(5341):1309-12. PubMed ID: 9360930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutively active ABL family kinases, TEL/ABL and TEL/ARG, harbor distinct leukemogenic activities in vivo.
    Yokota A; Hirai H; Shoji T; Maekawa T; Okuda K
    Leukemia; 2017 Dec; 31(12):2742-2751. PubMed ID: 28386107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia.
    Liu Q; Schwaller J; Kutok J; Cain D; Aster JC; Williams IR; Gilliland DG
    EMBO J; 2000 Apr; 19(8):1827-38. PubMed ID: 10775267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13).
    Wlodarska I; Mecucci C; Marynen P; Guo C; Franckx D; La Starza R; Aventin A; Bosly A; Martelli MF; Cassiman JJ
    Blood; 1995 May; 85(10):2848-52. PubMed ID: 7742547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription.
    Hiebert SW; Sun W; Davis JN; Golub T; Shurtleff S; Buijs A; Downing JR; Grosveld G; Roussell MF; Gilliland DG; Lenny N; Meyers S
    Mol Cell Biol; 1996 Apr; 16(4):1349-55. PubMed ID: 8657108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3'-kinase/protein kinase B signaling pathway.
    Nguyen MH; Ho JM; Beattie BK; Barber DL
    J Biol Chem; 2001 Aug; 276(35):32704-13. PubMed ID: 11435425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of the novel chimeric gene TEL/PTPRR in acute myelogenous leukemia with inv(12)(p13q13).
    Nakamura F; Nakamura Y; Maki K; Sato Y; Mitani K
    Cancer Res; 2005 Aug; 65(15):6612-21. PubMed ID: 16061641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms.
    Golub TR; Barker GF; Stegmaier K; Gilliland DG
    Curr Top Microbiol Immunol; 1997; 220():67-79. PubMed ID: 9103676
    [No Abstract]   [Full Text] [Related]  

  • 18. Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11.
    Buijs A; Sherr S; van Baal S; van Bezouw S; van der Plas D; Geurts van Kessel A; Riegman P; Lekanne Deprez R; Zwarthoff E; Hagemeijer A
    Oncogene; 1995 Apr; 10(8):1511-9. PubMed ID: 7731705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia.
    Peeters P; Raynaud SD; Cools J; Wlodarska I; Grosgeorge J; Philip P; Monpoux F; Van Rompaey L; Baens M; Van den Berghe H; Marynen P
    Blood; 1997 Oct; 90(7):2535-40. PubMed ID: 9326218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel activation of ABL by fusion to an ets-related gene, TEL.
    Papadopoulos P; Ridge SA; Boucher CA; Stocking C; Wiedemann LM
    Cancer Res; 1995 Jan; 55(1):34-8. PubMed ID: 7805037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.